6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
21m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
21m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
45m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
45m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
45m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Viking Therapeutics Inc (NASDAQ:VKTX) — investor relations, events, news, and company updates on 6ix.

Latest News

Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735

Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update

Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026

Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity

Financials

Revenue

$0

Market Cap

$4.02 B

EPS

-3.19

Community Chat

Ask AI